Operating Income Summary of CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited's latest annual operating income in 2023 was 7.68 Billion HKD , down -1.99% from previous year.
CSPC Pharmaceutical Group Limited's latest quarterly operating income in 2024 Q2 was 3.97 Billion HKD , down 0.0% from previous quarter.
CSPC Pharmaceutical Group Limited reported an annual operating income of 7.89 Billion HKD in 2022, up 4.87% from previous year.
CSPC Pharmaceutical Group Limited reported an annual operating income of 7.52 Billion HKD in 2021, up 23.26% from previous year.
CSPC Pharmaceutical Group Limited reported a quarterly operating income of 3.79 Billion HKD for 2023 Q4, up 96.14% from previous quarter.
CSPC Pharmaceutical Group Limited reported a quarterly operating income of 1.93 Billion CNY for 2023 Q3, up 1.44% from previous quarter.

Annual Operating Income Chart of CSPC Pharmaceutical Group Limited (2023 - 2003)

Historical Annual Operating Income of CSPC Pharmaceutical Group Limited (2023 - 2003)

Year	Operating Income	Operating Income Growth
2023	7.68 Billion HKD	-1.99%
2022	7.89 Billion HKD	4.87%
2021	7.52 Billion HKD	23.26%
2020	6.1 Billion HKD	21.01%
2019	5.04 Billion HKD	24.48%
2018	4.05 Billion HKD	40.38%
2017	2.88 Billion HKD	21.03%
2016	2.38 Billion HKD	32.28%
2015	1.8 Billion HKD	35.89%
2014	1.32 Billion HKD	30.31%
2013	1.01 Billion HKD	-46.26%
2012	1.89 Billion HKD	532.38%
2011	299.76 Million HKD	-65.02%
2010	856.86 Million HKD	-12.6%
2009	980.39 Million HKD	-8.05%
2008	1.06 Billion HKD	77.07%
2007	602.14 Million HKD	37432.57%
2006	1.6 Million HKD	-98.97%
2005	155.09 Million HKD	-47.33%
2004	294.43 Million HKD	-55.68%
2003	664.38 Million HKD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	3.97 Billion HKD	0.0%
2023 Q4	3.79 Billion HKD	96.14%
2023 Q3	1.93 Billion CNY	1.44%
2023 FY	7.73 Billion HKD	-1.99%
2023 Q2	1.9 Billion CNY	9.27%
2023 Q1	1.74 Billion HKD	-53.19%
2022 Q4	3.72 Billion HKD	0.0%
2022 FY	7.89 Billion HKD	4.87%
2022 Q2	4.18 Billion HKD	0.0%
2021 Q2	3.73 Billion HKD	0.0%
2021 FY	7.52 Billion HKD	23.26%
2021 Q4	3.79 Billion HKD	0.0%
2020 Q2	2.77 Billion HKD	0.0%
2020 Q4	3.33 Billion HKD	0.0%
2020 FY	6.1 Billion HKD	21.01%
2019 FY	5.04 Billion HKD	24.48%
2019 Q4	2.43 Billion HKD	0.0%
2019 Q2	2.61 Billion HKD	0.0%
2018 Q1	1.01 Billion HKD	0.0%
2018 Q2	1.01 Billion HKD	0.0%
2018 Q3	1.04 Billion HKD	3.28%
2018 Q4	1.15 Billion HKD	10.82%
2018 FY	4.05 Billion HKD	40.38%
2017 FY	2.88 Billion HKD	21.03%
2017 Q4	1.01 Billion HKD	10.52%
2017 Q3	916.94 Million HKD	26.04%
2017 Q2	727.47 Million HKD	0.0%
2017 Q1	727.47 Million HKD	0.0%
2016 FY	2.38 Billion HKD	32.28%
2016 Q4	727.47 Million HKD	7.59%
2016 Q3	676.17 Million HKD	13.36%
2016 Q2	596.48 Million HKD	0.0%
2016 Q1	596.48 Million HKD	0.0%
2015 Q3	450.93 Million HKD	0.0%
2015 FY	1.8 Billion HKD	35.89%
2015 Q1	450.93 Million HKD	0.0%
2015 Q4	596.48 Million HKD	32.28%
2015 Q2	450.93 Million HKD	0.0%
2014 Q3	331.84 Million HKD	0.0%
2014 FY	1.32 Billion HKD	30.31%
2014 Q2	331.84 Million HKD	0.0%
2014 Q1	331.84 Million HKD	0.0%
2014 Q4	450.93 Million HKD	35.89%
2013 Q3	254.66 Million HKD	0.0%
2013 Q4	331.84 Million HKD	30.31%
2013 Q2	254.66 Million HKD	0.0%
2013 Q1	254.66 Million HKD	0.0%
2013 FY	1.01 Billion HKD	-46.26%
2012 Q4	254.66 Million HKD	-46.26%
2012 Q3	473.91 Million HKD	0.0%
2012 Q1	473.91 Million HKD	0.0%
2012 FY	1.89 Billion HKD	532.38%
2012 Q2	473.91 Million HKD	0.0%
2011 Q4	473.91 Million HKD	532.38%
2011 Q1	74.94 Million HKD	0.0%
2011 Q2	74.94 Million HKD	0.0%
2011 Q3	74.94 Million HKD	0.0%
2011 FY	299.76 Million HKD	-65.02%
2010 Q3	214.21 Million HKD	0.0%
2010 FY	856.86 Million HKD	-12.6%
2010 Q2	214.21 Million HKD	0.0%
2010 Q1	214.21 Million HKD	0.0%
2010 Q4	74.94 Million HKD	-65.02%
2009 Q3	245.09 Million HKD	0.0%
2009 Q4	214.21 Million HKD	-12.6%
2009 FY	980.39 Million HKD	-8.05%
2009 Q1	245.09 Million HKD	0.0%
2009 Q2	245.09 Million HKD	0.0%
2008 Q4	245.09 Million HKD	-8.05%
2008 Q3	266.55 Million HKD	0.0%
2008 Q2	266.55 Million HKD	0.0%
2008 Q1	266.55 Million HKD	0.0%
2008 FY	1.06 Billion HKD	77.07%
2007 FY	602.14 Million HKD	37432.57%
2007 Q1	150.53 Million HKD	0.0%
2007 Q3	150.53 Million HKD	0.0%
2007 Q2	150.53 Million HKD	0.0%
2007 Q4	266.55 Million HKD	77.07%
2006 Q3	401.08 Thousand HKD	0.0%
2006 Q4	150.53 Million HKD	37432.57%
2006 FY	1.6 Million HKD	-98.97%
2006 Q1	401.08 Thousand HKD	0.0%
2006 Q2	401.08 Thousand HKD	0.0%
2005 Q4	401.08 Thousand HKD	-98.97%
2005 FY	155.09 Million HKD	-47.33%
2005 Q3	38.77 Million HKD	0.0%
2005 Q1	38.77 Million HKD	0.0%
2005 Q2	38.77 Million HKD	0.0%
2004 Q4	38.77 Million HKD	-47.33%
2004 Q1	73.6 Million HKD	0.0%
2004 Q3	73.6 Million HKD	0.0%
2004 Q2	73.6 Million HKD	0.0%
2004 FY	294.43 Million HKD	-55.68%
2003 Q3	166.09 Million HKD	0.0%
2003 Q2	166.09 Million HKD	0.0%
2003 Q1	166.09 Million HKD	0.0%
2003 FY	664.38 Million HKD	0.0%
2003 Q4	73.6 Million HKD	-55.68%
2002 Q4	166.09 Million HKD	0.0%

Peer Operating Income Comparison of CSPC Pharmaceutical Group Limited

Name	Operating Income	Operating Income Difference

Global Stocks Search

CSPC Pharmaceutical Group Limited (1093.HK)

Operating Income Summary of CSPC Pharmaceutical Group Limited

Annual Operating Income Chart of CSPC Pharmaceutical Group Limited (2023 - 2003)

Historical Annual Operating Income of CSPC Pharmaceutical Group Limited (2023 - 2003)

Peer Operating Income Comparison of CSPC Pharmaceutical Group Limited